Alzheimer's Disease – Alternative Treatment Methods

(Please do not use this text as a guide to action!)

I am writing this note solely to document publicly everything
I know about alternative treatment methods for Alzheimer's
disease in third-world countries. The reason is that in
impoverished nations, there is no insurance-based healthcare,
no possibility of performing a brain puncture, and no access
to digital electromagnetic diagnostics.
Therefore, Alzheimer's disease is treated quite differently
in these regions. Unlike in developed countries, doctors
in poor nations do not use neuroleptics to keep patients
in a vegetative state for life. In fact, Alzheimer's is considered
curable in some cases. I will try to explain why.
It is well known that Alzheimer's is caused by metabolic
disturbances in brain cells, where proteins accumulate and
toxins are not properly eliminated. This disruption affects
communication between neurons, leading to gradual mental
decline or forgetfulness of recent events. Overall, there
are about 50 types of Alzheimer's disease. Generally,
Alzheimer's is characterized by a set of similar symptoms.
Thus, like hypertension, the symptoms of Alzheimer's are
a consequence of metabolic disturbances in the brain, not
the disease itself. The root cause - protein plaques in brain
cells - can have various origins. In some cases, it is
treatable; in others, it is not. It all depends on the
underlying cause of the protein exchange disruption in brain
cells. In poor countries in Asia and Africa, because brain
puncture is risky and often not feasible due to damaged
brain tissue, alternative treatment methods are used.
Additionally, brain puncture analysis may be incomplete
or distorted if the puncture is performed on healthy tissue.
Therefore, the following therapies are employed:
1. Metabolic disruption caused by herpes zoster: Reactivated
herpes zoster in a latent or aggressive form can invade
the brain. In immunocompromised individuals, the virus
penetrates the blood-brain barrier and destroys neurons,
producing symptoms similar to Alzheimer's. In this case,
a full course of 8 days of oral Acyclovir is prescribed.
2. Fungal infections of the brain tissue: Often, symptoms
resemble Alzheimer's but are caused by partial fungal
invasion that cannot be diagnosed through blood tests alone.
In such cases, doctors in impoverished regions prescribe
broad-spectrum antifungal medications. The specific drugs
depend on the region, as fungi may affect only certain brain
areas rather than the entire brain.
3. Parasitic infections: Parasites that cross the blood-brain
barrier can also cause symptoms similar to Alzheimer's.
These infections include helminths (worms) and protozoa
such as amoebae, flagellates, ciliates, bacteria, etc. Blood
tests may show inflammation but not identify the cause.
Therefore, broad-spectrum antiparasitic drugs are used,
sometimes for up to a month.
4. Toxic metal poisoning: Another cause involves exposure
to toxins from metal implants or fragments, such as artificial
joints or metal bone connectors. Poor-quality implants or
shrapnel can gradually poison the brain. Blood tests in
independent laboratories are necessary to detect heavy
metals or toxins. Treatment involves removing the
contaminated implant or fragment.
5. Prion diseases: These cause symptoms similar to Alzheimer's
but are currently incurable. Prions are self-replicating proteins
that can only be destroyed by ultrasound. Unfortunately, no
effective treatments have been developed yet, but there is hope
that future technologies might eliminate prions within brain
tissue.
6. Vaccine-related cases: Symptoms resembling Alzheimer's
may occur after COVID-19 vaccination. In this scenario, vaccine
proteins accumulate in brain tissue, leading to memory loss and
abnormal behavior. Treatment involves detoxification and blood
purification. Notably, these symptoms tend to appear suddenly
within 3-5 years post-vaccination and can be identified through
blood tests detecting vaccine-related blood clots.
If none of these diagnostic or treatment methods are effective,
it is generally assumed that the patient has true, canonical
Alzheimer's disease rather than just similar symptoms.